For instance, it has been shown that MYCN-overexpressing neuroblastoma cells were selectively susceptible to CDK7 inhibition by suppressing their MYCN-associated super-enhancers-associated genes (Chipumuro et al., 2014). The gene discussed is MYCN; the disease is neuroblastoma.